Catheter Precision VTAK
NYSE VTAK
$0.20 -0.01 (-4.63%)
As of: Aug 20, 2026 · 3:59 PM EDT

Catheter Precision (VTAK) Revenue Growth (3y) (2020 - 2026)

Catheter Precision (VTAK) Revenue Growth (3y) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (3y) (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn 8.07%
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 9.66%
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 4.70%
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 14.78%
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn 10.83%
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn 14.51%
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 3.20%
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 25.44%
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 8.05%
10 Catheter Precision 564,834.50 -1.27 Mn 98,000.00 119.77%

Historic Data

Download Data
DateValue
Mar 31, 2026 71.93%
Jun 30, 2025 248.70%
Mar 31, 2025 151.40%
Dec 31, 2024 210.03%
Sep 30, 2024 167.77%
Jun 30, 2024 -54.77%
Mar 31, 2024 173.69%
Sep 30, 2023 25.06%
Jun 30, 2023 -52.57%
Mar 31, 2023 -60.45%
Jun 30, 2022 -86.76%
Mar 31, 2022 -82.73%
Dec 31, 2021 -86.40%
Sep 30, 2021 -86.57%
Jun 30, 2021 -6.66%
Mar 31, 2021 -83.96%
Sep 30, 2020 -62.51%